Evaluation of Treatment PERSOnalization Based on Its Therapeutic Monitoring in Patients With Metastatic Colorectal Cancer Treated With REgorafenib
NCT04874207
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
110
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer Metastatic
Interventions
DRUG:
Regorafenib
Sponsor
Rennes University Hospital